Celldex Therapeutics, Inc. - FORM 10-K - EX-21.1 - March 7, 2018

Attached files

file filename
EX-32 - EX-32 - Celldex Therapeutics, Inc.a2234429zex-32.htm
EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc.a2234429zex-31_2.htm
EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc.a2234429zex-31_1.htm
EX-23.1 - EX-23.1 - Celldex Therapeutics, Inc.a2234429zex-23_1.htm
EX-10.28 - EX-10.28 - Celldex Therapeutics, Inc.a2234429zex-10_28.htm
EX-10.27 - EX-10.27 - Celldex Therapeutics, Inc.a2234429zex-10_27.htm
EX-10.25 - EX-10.25 - Celldex Therapeutics, Inc.a2234429zex-10_25.htm
EX-10.24 - EX-10.24 - Celldex Therapeutics, Inc.a2234429zex-10_24.htm
10-K - 10-K - Celldex Therapeutics, Inc.a2234429z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 21.1

SUBSIDIARIES OF CELLDEX THERAPEUTICS, INC.

Name
  Jurisdiction of
Organization 		  Ownership
Percentage 		 

Celldex Australia PTY LTD

   Australia     100 %



QuickLinks

SUBSIDIARIES OF CELLDEX THERAPEUTICS, INC.

Celldex Therapeutics, Inc. Reports